EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Angiopoietin-like protein 2 mediates vasculopathy-driven fibrogenesis in a mouse model of systemic sclerosis

Dyuti Saha, Ravi Kiran Annadorai, Sujaya Thannimangalath, Neha P Shroff, Sunny Kataria, Binita Dam, Abhik Dutta, Akshay Hegde, Ankita Hiwale, Venkatesh Ravula, Shagnik Saha, Lekshmi Minikumari Rahulan und 5 weitere

Journal of Clinical Investigation · 2025

DOI: 10.1172/jci177123 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2025. Verfasst von Dyuti Saha und 16 weiteren Autor:innen. Beteiligte Einrichtung: IFOM-inStem Joint Research Laboratory, Institute for Stem Cell Science and Regenerative Medicine, Bangalore, India. Hauptthemen laut MEDLINE: Angiopoietin-like Proteins, Scleroderma, Systemic, Angiopoietins. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Institute for Stem Cell Science and Regenerative Medicine, Shiv Nadar Institution of Eminence, Department of Biotechnology of the Government of India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vasculopathy is a common hallmark of various fibrotic disorders, including systemic sclerosis (SSc), yet its underlying etiology and contribution to fibrogenesis remain ill defined. In SSc, the vasculopathy typically precedes the onset of fibrosis, and we observed that this phenomenon is recapitulated in the Snail transgenic mouse model of SSc. The vascular anomalies manifest as deformed vessels, endothelial cell dysfunction, and vascular leakage. Our investigation into the underlying mechanism of this phenotype revealed that angiopoietin-like protein 2 (ANGPTL2), secreted by the Snail transgenic keratinocytes, is a principal driver of fibrotic vasculopathy. In endothelial cells, ANGPTL2 upregulates profibrotic genes, downregulates various junctional proteins, and prompts the acquisition of mesenchymal characteristics. Inhibiting endothelial cell junctional instability and, consequently, vascular leakage with a synthetic analog of the microbial metabolite Urolithin A (UAS03) effectively mitigated the vasculopathy and inhibited fibrogenesis. Thus, ANGPTL2 is a promising early biomarker of the disease, and inhibiting the vasculopathy-inducing effects of this protein with agents such as UAS03 presents an appealing therapeutic avenue to reduce disease severity. These insights hold the potential to revolutionize the approach to treatment of fibrotic diseases by targeting vascular defects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Angiopoietin-like ProteinsScleroderma, SystemicAngiopoietinsAnimalsAngiopoietin-Like Protein 2MiceDisease Models, AnimalFibrosisMice, TransgenicHumansEndothelial CellsKeratinocytes

Stichwörter der Autor:innen

Cell biologyDermatologyEndothelial cellsFibrosisSkinVascular biology

Substanzen

Angiopoietin-Like Protein 2Angiopoietin-like ProteinsAngptl2 protein, mouseANGPTL2 protein, humanAngiopoietins

Autor:innen und Institutionen

  • IFOM-inStem Joint Research Laboratory, Institute for Stem Cell Science and Regenerative Medicine, Bangalore, India.
  • Department of Biology, Manipal Academy of Higher Education, Manipal, India.
  • Department of Life Sciences, Shiv Nadar Institution of Eminence, Delhi-NCR, India.
  • School of Chemical and Biotechnology, Shanmugha Arts, Science, Technology and Research Academy, Thanjavur, Tamil Nadu, India.
  • Laboratory of Chemical Biology and Translational Research, Institute for Stem Cell Science and Regenerative Medicine (DBT-inStem), Bangalore, India.
  • Center of Excellence in Epigenetics, Department of Life Sciences, Shiv Nadar Institution of Eminence, Delhi-NCR, India.

Förderung

  • Institute for Stem Cell Science and Regenerative Medicine
  • Shiv Nadar Institution of Eminence
  • Department of Biotechnology of the Government of India
  • Indian Council of Medical Research
  • Department of Biotechnology , Ministry of Science and Technology
  • Department of Science and Technology, Ministry of Science and Technology

Zitieren

APA

Saha, D., Annadorai, R. K., Thannimangalath, S., Shroff, N. P., Kataria, S., Dam, B., Dutta, A., Hegde, A., Hiwale, A., Ravula, V., Saha, S., Minikumari Rahulan, L., Nigam, N., Singh, N., Agarwal, V., Vemula, P. K., & Jamora, C. (2025). Angiopoietin-like protein 2 mediates vasculopathy-driven fibrogenesis in a mouse model of systemic sclerosis. Journal of Clinical Investigation. https://doi.org/10.1172/jci177123

Vancouver

Saha D, Annadorai RK, Thannimangalath S, Shroff NP, Kataria S, Dam B, et al. Angiopoietin-like protein 2 mediates vasculopathy-driven fibrogenesis in a mouse model of systemic sclerosis. Journal of Clinical Investigation. 2025. doi:10.1172/jci177123

BibTeX
@article{Saha2025,
  author = {Saha, Dyuti and Annadorai, Ravi Kiran and Thannimangalath, Sujaya and Shroff, Neha P and Kataria, Sunny and Dam, Binita and Dutta, Abhik and Hegde, Akshay and Hiwale, Ankita and Ravula, Venkatesh and Saha, Shagnik and Minikumari Rahulan, Lekshmi and Nigam, Neha and Singh, Neha and Agarwal, Vikas and Vemula, Praveen K and Jamora, Colin},
  title = {Angiopoietin-like protein 2 mediates vasculopathy-driven fibrogenesis in a mouse model of systemic sclerosis},
  journal = {Journal of Clinical Investigation},
  year = {2025},
  doi = {10.1172/jci177123}
}
Kostenlos starten →